newsfilter
← Latest News
GlobeNewswire·

Baudax Bio to Participate in the H.C. Wainwright Global Investment Conference

MALVERN, Pa., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (the "Company" or "Baudax Bio") (NASDAQ:BXRX), a biotechnology company focused on developing T cell receptor ("TCR") therapies utilizing human